Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2020-04-13 Knowles Julius Director Conversion · Series B-1 Preferred Stock −205,962 0
2020-04-13 Knowles Julius Director Conversion · Series B-1 Preferred Stock −137,308 0
2020-04-13 Knowles Julius Director Conversion · Series C Preferred Stock −67,015 0
2020-04-13 Knowles Julius Director Conversion · Series C Preferred Stock −44,676 0
2020-04-13 Kariv Tomer Director Conversion +1,363,542 1,734,395
2020-04-13 Kariv Tomer Director Conversion +663,825 844,371
2020-04-13 Kariv Tomer Director Conversion +737,226 937,735
2020-04-13 Kariv Tomer Director Conversion +169,307 1,903,702
2020-04-13 Kariv Tomer Director Conversion +82,425 926,796
2020-04-13 Kariv Tomer Director Conversion +91,538 1,029,273
2020-04-13 Kariv Tomer Director Conversion +68,654 68,654
2020-04-13 Kariv Tomer Director Conversion +163,612 2,067,314
2020-04-13 Kariv Tomer Director Conversion +88,460 1,015,256
2020-04-13 Kariv Tomer Director Conversion +79,653 1,108,926
2020-04-13 Kariv Tomer Director Conversion +36,858 105,512
2020-04-13 Kariv Tomer Director Purchase +194,203 $16.00 $3.1M 2,261,517
2020-04-13 Kariv Tomer Director Purchase +94,546 $16.00 $1.5M 1,109,802
2020-04-13 Kariv Tomer Director Purchase +105,000 $16.00 $1.7M 1,213,926
2020-04-13 Kariv Tomer Director Purchase +43,750 $16.00 $700K 149,262
2020-04-13 Kariv Tomer Director Conversion · Series A Preferred Stock −1,363,542 0

Page 34 of 36 · 707 trades